07.24.25 -- The Potential Impact Of U.S. Tariffs On The Biotech Sector

The current U.S. deregulatory momentum should not diminish compliance standards but instead serve as a call to streamline and modernize regulatory guidance.

This panel of biotech, pharma, and CRO leaders discusses how precision medicine, data-driven tools, and biomarkers are transforming clinical research and trial strategies globally.

Document review is a hidden bottleneck in biopharma. Learn how inefficiencies in this critical process can delay drug development and what you can do to accelerate time to market.

Discover how ethnobridging streamlines the approval process in Asian markets and addresses potential disparities in drug metabolism between Asian and non-Asian populations.

Explore the growing impact of Real-World Evidence (RWE) on clinical trials, particularly in rare disease research.

Discover how robotic gloveless isolator sterile fill-finish (SFF) systems can accelerate early-phase drug development, ensuring enhanced sterility and streamlined processes for biopharma innovation.

The full-service Contract Research Organization (CRO) with operations in Australia, New Zealand, Asia, North America, and Europe.

With over 6,000 tooling parts and an in-house machining center to ensure precision, explore this versatile blister service that provides both Thermoformed and Cold-Formed solutions.